AlprolixTM is an approved drug (FDA (2014))
Compound class:
Peptide or derivative
Comment: AlprolixTM is a recombinant fusion protein combining the peptide for coagulation factor IX with an antibody Fc domain. The presence of the Fc domain increases protein half-life and extends the drug's therapeutic window.
|
Classification  |
|
| Compound class | Peptide or derivative |
| Approved drug? | Yes (FDA (2014)) |
| Database Links |
|
| GtoPdb PubChem SID | 178103945 |
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
